Skip to main content
. Author manuscript; available in PMC: 2016 Jan 14.
Published in final edited form as: J Blood Disord Transfus. 2014 Mar 22;5(4):206. doi: 10.4172/2155-9864.1000206

Figure 6.

Figure 6

FBS− BM-DC treatment prevents T1D onset. NOD were treated with 1×105 FBS+ BM-DC, FBS− BM-DC or PBS once per week for 5 weeks and T1D onset was monitored for 20 weeks (n=12). Survival curve was analyzed using a Gehan-Breslow-Wilcoxon test.